University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Foltynie, T"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 6.


Athauda, Dilan, Gulyani, Seema, Karnati, Hanuma kumar, Li, Yazhou, Tweedie, David, Mustapic, Maja, Chawla, Sahil, Chowdhury, Kashfia, Skene, Simon S., Greig, Nigel H., Kapogiannis, Dimitrios and Foltynie, Thomas (2019) Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease JAMA Neurology, 76 (4).

Athauda, Dilan, Maclagan, Kate, Budnik, Natalia, Zampedri, Luca, Hibbert, Steve, Aviles-Olmos, Iciar, Chowdhury, Kashfia, Skene, Simon S., Limousin, Patricia and Foltynie, Thomas (2018) Post hoc analysis of the Exenatide-PD trial-Factors that predict response European Journal of Neuroscience, 49 (3). pp. 410-421.

Athauda, Dilan, Maclagan, Kate, Budnik, Natalia, Zampedri, Luca, Hibbert, Steve, Skene, Simon S., Chowdhury, Kashfia, Aviles-Olmos, Iciar, Limousin, Patricia and Foltynie, Thomas (2018) What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis Journal of Parkinson's Disease, 8 (2). pp. 247-258.

Athauda, D, Maclagan, K, Skene, S, Bajwa-Joseph, M, Letchford, D, Chowdhury, K, Hibbert, S, Budnik, N, Zampedri, L, Dickson, J, Li, Y, Aviles-Olmos,, I, Warner, T T, Limousin, P, Lees, A J, Greig, N H, Tebbs, S and Foltynie, T (2017) Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. The Lancet, 390 (10103). pp1664-1675.

Healy, DG, Abou-Sleiman, PM, Casas, JP, Ahmadi, KR, Lynch, T, Gandhi, S, Muqit, MM, Foltynie, T, Barker, R, Bhatia, KP, Quinn, NP, Lees, AJ, Gibson, JM, Holton, JL, Revesz, T, Goldstein, DB and Wood, NW (2006) UCHL-1 is not a Parkinson's disease susceptibility gene. Ann Neurol, 59 (4). pp. 627-633.

Conference or Workshop Item

Athauda, D., Budnik, N., Chowdhury, K., Skene, S. and Foltynie, T. (2018) The effect of exenatide on specific non-motor symptoms in Parkinson’s disease – a post-hoc analysis. In: 4th Congress of the European Academy of Neurology, 2018-06-16-2018-06-19, Lisbon, Portugal.

This list was generated on Sun May 31 06:36:44 2020 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800